For a person who has a rare or particularly debilitating condition, there are two things that sit highest in their minds most of the time: getting treatment for their condition and getting access to the disability benefits they deserve. Unfortunately for some though, a condition may be so rare that it may not be seen as a disabling condition by the Social Security Administration. In other cases, there may not be a treatment, oftentimes meaning a high chance of mortality.
While a skilled attorney can oftentimes help someone get the disability benefits they deserve, an attorney can do little about getting them the treatments they may need to prolong their life. This is where Pfizer is looking to step in, especially in the area of rare diseases. Thanks to an expansion of their research and development department, the pharmaceutical company may finally be able to provide treatments where none existed before.